# Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy

> **NCT01823185** · PHASE4 · UNKNOWN · sponsor: **Imam Abdulrahman Bin Faisal University** · enrollment: 1500 (estimated)

## Conditions studied

- Coronary Artery Disease
- Myocardial Infarction
- Heart Disease
- Vascular Disease
- Angina Pectoris
- Cardiovascular Disease
- Ischemia
- Infarction
- Embolism
- Thrombosis
- Chest Pain

## Interventions

- **DRUG:** clopidogrel
- **DRUG:** Ticagrelor or prasugrel

## Key facts

- **NCT ID:** NCT01823185
- **Lead sponsor:** Imam Abdulrahman Bin Faisal University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2016-01
- **Final completion:** 2016-03
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2016-01-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01823185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01823185, "Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01823185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*